Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: ViewFlex X ICE First-in-Human Study

View source ↗

Summary

ViewFlex X ICE’s first-in-human study is currently recruiting for cardiac arrhythmias. Abbott Medical Devices is listed as the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ViewFlex X ICE

Snippet

Sponsor: Abbott Medical Devices | Conditions: Cardiac Arrhythmias | Status: RECRUITING